Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis

The lung immune prognostic index (LIPI) has been shown to be an important prognostic marker for various tumors. However, the prognostic value of LIPI among non-small cell lung cancer (NSCLC) patients treated with systemic therapy remains controversial. We aimed to evaluate survival status according...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Litang, Han, Hedong, Zhou, Li, Chen, Xi, Xu, Qiuli, Xie, Jingyuan, Zhan, Ping, Chen, Si, Lv, Tangfeng, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264771/
https://www.ncbi.nlm.nih.gov/pubmed/34249708
http://dx.doi.org/10.3389/fonc.2021.670230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264771/
https://www.ncbi.nlm.nih.gov/pubmed/34249708
http://dx.doi.org/10.3389/fonc.2021.670230

Ejemplares similares